Back to Authors

Bandekar, Rajesh

A5062101208 | I4210151386

Mayo Clinic

Janssen Research and Development, Spring House, PA

Citations 2

Efficacy of siltuximab in patients with previously treated multicentric Castleman’s disease (MCD).

Journal of Clinical Oncology | January 3, 2019 | Volume: 32 | Issue: 15_suppl | Pages: 8514-8514

10.1200/jco.2014.32.15_suppl.8514

Randomized, open-label, phase 3 study of subcutaneous daratumumab (DARA SC) versus active monitoring in patients (Pts) with high-risk smoldering multiple myeloma (SMM): AQUILA.

Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: TPS8062-TPS8062

10.1200/jco.2018.36.15_suppl.tps8062